| Dictyostelium myosin I double mutants exhibit conditional defects in pinocytosis. KD Novak, MD Peterson, MC Reedy, MA Titus The Journal of cell biology 131 (5), 1205-1221, 1995 | 224 | 1995 |
| Myosin I overexpression impairs cell migration KD Novak, MA Titus The Journal of cell biology 136 (3), 633-647, 1997 | 102 | 1997 |
| Lymphotoxin activation by human T-cell leukemia virus type I-infected cell lines: role for NF-kappa B NL Paul, MJ Lenardo, KD Novak, T Sarr, WL Tang, NH Ruddle Journal of virology 64 (11), 5412-5419, 1990 | 95 | 1990 |
| Examination of the endosomal and lysosomal pathways in Dictyostelium discoideum myosin I mutants LA Temesvari, JM Bush, MD Peterson, KD Novak, MA Titus, JA Cardelli Journal of cell science 109 (3), 663-673, 1996 | 82 | 1996 |
| The myosin I SH3 domain and TEDS rule phosphorylation site are required for in vivo function KD Novak, MA Titus Molecular biology of the cell 9 (1), 75-88, 1998 | 75 | 1998 |
| Hepatocyte growth factor/scatter factor is a neurotrophic survival factor for lumbar but not for other somatic motoneurons in the chick embryo KD Novak, D Prevette, S Wang, TW Gould, RW Oppenheim Journal of Neuroscience 20 (1), 326-337, 2000 | 68 | 2000 |
| Epigenetics Changes in Cancer Cells: Highlights of the American Association for Cancer Research Special Conference on Chromatin, Chromosomes, and Cancer Epigenetics; November … K Novak Medscape General Medicine 6 (4), 2004 | 58 | 2004 |
| Molecular genetic analysis of myoc, a Dictyostelium myosin I MD Peterson, KD Novak, MC Reedy, JI Ruman, MA Titus Journal of cell science 108 (3), 1093-1103, 1995 | 56 | 1995 |
| Interaction between NF-κB-and serum response factor-binding elements activates an interleukin-2 receptor α-chain enhancer specifically in T lymphocytes AA Kuang, KD Novak, SM Kang, K Bruhn, MJ Lenardo Molecular and cellular biology, 1993 | 48 | 1993 |
| Angiogenesis inhibitors revised and revived at AACR K Novak Nature Medicine 8 (5), 427, 2002 | 27 | 2002 |
| NIH increase efforts to tackle obesity K Novak Nature Medicine 4 (7), 752-753, 1998 | 24 | 1998 |
| Molecular genetic analysis of myoF, a new Dictyostelium myosin I gene. MA Titus, KD Novak, GP Hanes, AS Urioste Biophysical journal 68 (4 Suppl), 152S, 1995 | 24 | 1995 |
| Conference Report–Protein Kinase Inhibitors in Cancer Treatment: Mixing and Matching?: Highlights of the Keystone Symposium on Protein Kinases and Cancer; February 24–29, 2004 … K Novak Medscape General Medicine 6 (2), 2004 | 22 | 2004 |
| Taking out the trash K Novak Nature Reviews Drug Discovery 5 (2), 104-105, 2006 | 19 | 2006 |
| Cardiovascular disease increasing in developing countries. K Novak Nature medicine 4 (9), 989-990, 1998 | 18 | 1998 |
| Passive smoking: out from the haze. K Novak Nature 447 (7148), 1049-1052, 2007 | 16 | 2007 |
| The WTO’s balancing act K Novak The Journal of clinical investigation 112 (9), 1269-1273, 2003 | 16 | 2003 |
| US FDA to issue new rules on xenotransplantation K Novak Nat Med 4, 876, 1998 | 16 | 1998 |
| Myosin I phosphorylation is increased by chemotactic stimulation NR Gliksman, G Santoyo, KD Novak, MA Titus Journal of Biological Chemistry 276 (7), 5235-5239, 2001 | 13 | 2001 |
| Spider venom helps hearts keep their rhythm K Novak Nature Medicine 7 (2), 155-155, 2001 | 13 | 2001 |
